Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Weight Gain Associated with Levothyroxine Treatment

Mechanisms of Weight Gain

  • Overtreatment with levothyroxine can lead to iatrogenic hyperthyroidism, resulting in weight gain, as reported by the American College of Physicians, with about 25% of patients on levothyroxine being unintentionally maintained on doses high enough to suppress TSH completely 1
  • Undertreatment with levothyroxine may not fully address the metabolic effects of hypothyroidism, potentially leading to weight gain, according to clinical guidelines 2

Monitoring and Management

  • Regular monitoring of TSH levels every 6-8 weeks while titrating hormone replacement, and then every 6-12 months once stable, is essential to prevent both overtreatment and undertreatment, as recommended by clinical guidelines 2
  • Overtreatment with levothyroxine can increase the risk for osteoporosis, fractures, abnormal cardiac output, and ventricular hypertrophy, highlighting the importance of appropriate dosing, as reported in the Annals of Internal Medicine 1
  • Appropriate dosing is critical, with the full replacement dose being approximately 1.6 mcg/kg/day for patients under 70 years without cardiac disease, and starting with 25-50 mcg/day and titrating gradually for patients over 70 years or with cardiac disease, according to clinical guidelines 2

REFERENCES

2

Initial Treatment for Elevated TSH [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025